The market is not reacting favorably to the deal and obviously does not like it. My concern right now is the fact that ACAS bought back around 46%+ of the outstanding shares, and the NAV is supposedly up over $20 right now, yet this deal is for just $17.40 per fully diluted share, and the market is actually valuing it below that level. Time will tell, but this does not look like the best outcome to me right now.
News 
Market Data 
Discover 
